Welcome to Alberta.
A dynamic ecosystem to conduct clinical trials.
World-class research capabilities, a diverse patient population and an effective ethics framework make Alberta a premier destination to conduct high-quality clinical trials.
If you’re considering where to conduct your next clinical trial—it’s time you considered Alberta.
Alberta offers a dynamic clinical trial environment where academic institutes, research organizations and investigators collaborate with industry to pursue the development of new treatments and technologies that improve the health of people across the globe.
That’s why hundreds of industry partners – from startups to multinational organizations – rely on Alberta’s capabilities to conduct groundbreaking clinical trials across a range of therapeutic areas.
Why choose Alberta for your clinical trial?
Our province’s unique advantages enable increased trial efficiencies, reduced operating costs, and faster times to market, all while maintaining the highest quality standards.
Efficiency
Centralized and streamlined provincial processes contribute to efficiency at every stage of the research lifecycle.
Quality
Highly skilled investigators, cutting-edge facilities and an integrated healthcare environment enable high-quality clinical trials.
Incentives
An innovative, business-friendly environment and competitive tax incentives for R&D activities.
News and Stories
IMPACT helps a new medical device find its way to market
The IMPACT Clinical Trial Accelerator Program has a unique mission – to help new ventures and startups in the life science sector commercialize their inventions.
Read More
Setting a new standard of care for Ischemic Stroke patients
In 2016, Alberta researchers conducted a groundbreaking multi-site study that changed the global standard of care for Ischemic Stroke.
Read More
Creating an informed and supportive participant population
Be The Cure – Alberta’s clinical research public awareness initiative – is creating an informed, primed and supportive participant population.
Read More
Alberta’s integrated health system provides tremendous value to provincial COVID research
“Some of the amazing things we accomplished with the CATCO trial would not have been possible to do in many other places,” notes Dr. Tremblay. “It’s a testament to what is possible in our province.”
Read More
Introducing the REB Exchange
Alberta’s new centralized ethics submission platform – the REB Exchange – has launched. The platform allows a single ethics submission to cover most sites across the province.
Read More
Alberta Cell Therapy Manufacturing – Enabling the future of medicine
Regenerative medicine and cell therapies are the future of medicine. They offer the potential to transform the treatment of disease such as cancer and diabetes and the ability to replace damaged tissues and organs, make cartilage for joint repair, and create new therapies to treat autoimmune diseases and organ transplant rejection. The University of Alberta’s Alberta Cell Therapy Manufacturing (ACTM) facility is helping make this future a reality.
Read More
Introducing Alberta’s new ethics submission platform: The REB Exchange
Regenerative medicine and cell therapies are the future of medicine. They offer the potential to transform the treatment of disease such as cancer and diabetes and the ability to replace damaged tissues and organs, make cartilage for joint repair, and create new therapies to treat autoimmune diseases and organ transplant rejection. The University of Alberta’s Alberta Cell Therapy Manufacturing (ACTM) facility can help make this future a reality.
Read More
If you’re seeking an Alberta investigator or site for your clinical trial, we can help.
Clinical Trials Alberta can help you navigate the Alberta research environment and accelerate your trials by:
-
Providing information about conducting clinical trials in Alberta, including regulatory and ethics information.
-
Identifying and connecting you to relevant investigators, research sites, trial networks and service providers.
-
Addressing project-related concerns and challenges.